Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.555 USD | -2.81% | -3.42% | -36.79% |
16/05 | Spectral AI, Inc. Appoints Erich Spangenberg as A Director | CI |
09/05 | Spectral AI, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The stock, which is currently worth 2024 to 0.4 times its sales, is clearly overvalued in comparison with peers.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Low profitability weakens the company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-36.79% | 27.97M | - | ||
-7.06% | 27.7B | C | ||
+26.24% | 8.46B | C- | ||
+28.37% | 4.3B | B- | ||
-33.27% | 2.41B | C- | ||
-8.20% | 1.62B | - | C+ | |
-18.50% | 1.45B | B | ||
-33.46% | 1.16B | - | ||
+1.16% | 919M | C | ||
-40.00% | 830M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- MDAI Stock
- Ratings Spectral AI, Inc.